Journal articles on the topic 'Pneumonic Tularemia'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pneumonic Tularemia.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Ellis, Jill, Petra C. F. Oyston, Michael Green, and Richard W. Titball. "Tularemia." Clinical Microbiology Reviews 15, no. 4 (October 2002): 631–46. http://dx.doi.org/10.1128/cmr.15.4.631-646.2002.
Full textHORN, M., and L. ZICKUHR. "PNEUMONIC TULAREMIA: A CASE PRESENTATION." Chest 161, no. 6 (June 2022): A142. http://dx.doi.org/10.1016/j.chest.2021.12.174.
Full textGregory, Stephen H., Stephanie Mott, Jennifer Phung, Jinhee Lee, Leonard Moise, Julie A. McMurry, William Martin, and Anne S. De Groot. "Epitope-based vaccination against pneumonic tularemia." Vaccine 27, no. 39 (August 2009): 5299–306. http://dx.doi.org/10.1016/j.vaccine.2009.06.101.
Full textBonnier, Alyssa, Santu Saha, Adam Austin, and Biplab K. Saha. "An Unusual Etiology of Fluorodeoxyglucose Avid Intrathoracic Lymph Nodes." Prague Medical Report 125, no. 1 (2024): 79–86. http://dx.doi.org/10.14712/23362936.2024.8.
Full textNicol, McKayla J., David R. Williamson, David E. Place, and Girish S. Kirimanjeswara. "Differential Immune Response Following Intranasal and Intradermal Infection with Francisella tularensis: Implications for Vaccine Development." Microorganisms 9, no. 5 (April 30, 2021): 973. http://dx.doi.org/10.3390/microorganisms9050973.
Full textNelson, Christina A., Jessica Winberg, Taylor D. Bostic, K. Meryl Davis, and Shannon Fleck-Derderian. "Systematic Review: Clinical Features, Antimicrobial Treatment, and Outcomes of Human Tularemia, 1993–2023." Clinical Infectious Diseases 78, Supplement_1 (January 31, 2024): S15—S28. http://dx.doi.org/10.1093/cid/ciad736.
Full textJacobs, Richard F., Yoland M. Condrey, and Terry Yamauchi. "Tularemia in Adults and Children: A Changing Presentation." Pediatrics 76, no. 5 (November 1, 1985): 818–22. http://dx.doi.org/10.1542/peds.76.5.818.
Full textLovchik, Julie A., Douglas S. Reed, Julie A. Hutt, Fangfang Xia, Rick L. Stevens, Thero Modise, Eileen M. Barry, and Terry H. Wu. "Identification of an Attenuated Substrain of Francisella tularensis SCHU S4 by Phenotypic and Genotypic Analyses." Pathogens 10, no. 6 (May 22, 2021): 638. http://dx.doi.org/10.3390/pathogens10060638.
Full textWilliams, Mark S. "Efficacy of Doxycycline and Ciprofloxacin for Treatment of Pneumonic Tularemia in Cynomolgus Macaques." Clinical Infectious Diseases 78, Supplement_1 (January 31, 2024): S7—S14. http://dx.doi.org/10.1093/cid/ciad668.
Full textHahn, Mark M., Cheryl A. Triplett, Michael S. Anderson, Jennifer I. Smart, Karine Litherland, Stephen Keech, Franziska von Siebenthal, Mark Jones, Andrew J. Phipps, and Lisa N. Henning. "Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia." Antibiotics 12, no. 8 (August 19, 2023): 1337. http://dx.doi.org/10.3390/antibiotics12081337.
Full textMIR, MAHNOOR, and CHRISTOPHER DAYTON. "A CASE OF PNEUMONIC TULAREMIA MIMICKING COVID-19." Chest 160, no. 4 (October 2021): A373. http://dx.doi.org/10.1016/j.chest.2021.07.374.
Full textMaranan, Melinda C., Deborah Schiff, Daniel C. Johnson, Cyril Abrahams, Mark Wylam, and Susan I. Gerber. "Pneumonic Tularemia in a Patient with Chronic Granulomatous Disease." Clinical Infectious Diseases 25, no. 3 (September 1997): 630–33. http://dx.doi.org/10.1086/513777.
Full textFeldman, Katherine A., Russell E. Enscore, Sarah L. Lathrop, Bela T. Matyas, Michael McGuill, Martin E. Schriefer, Donna Stiles-Enos, David T. Dennis, Lyle R. Petersen, and Edward B. Hayes. "An Outbreak of Primary Pneumonic Tularemia on Martha's Vineyard." New England Journal of Medicine 345, no. 22 (November 29, 2001): 1601–6. http://dx.doi.org/10.1056/nejmoa011374.
Full textFrick, Ondraya M., Virginia A. Livingston, Chris A. Whitehouse, Sarah L. Norris, Derron A. Alves, Paul R. Facemire, Douglas S. Reed, and Aysegul Nalca. "The Natural History of Aerosolized Francisella tularensis Infection in Cynomolgus Macaques." Pathogens 10, no. 5 (May 13, 2021): 597. http://dx.doi.org/10.3390/pathogens10050597.
Full textPeriasamy, Sivakumar, Timothy Sellati, and Jonathan Harton. "Lung infiltrates containing myeloid-derived suppressor cells impair protective immunity in pneumonic tularemia caused by Francisella tularemia (P3082)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 187.14. http://dx.doi.org/10.4049/jimmunol.190.supp.187.14.
Full textCowley, Siobhán C. "Editorial: Proinflammatory cytokines in pneumonic tularemia: too much too late?" Journal of Leukocyte Biology 86, no. 3 (September 2009): 469–70. http://dx.doi.org/10.1189/jlb.0309119.
Full textMATYAS, B. T., H. S. NIEDER, and S. R. TELFORD. "Pneumonic Tularemia on Martha's Vineyard: Clinical, Epidemiologic, and Ecological Characteristics." Annals of the New York Academy of Sciences 1105, no. 1 (March 29, 2007): 351–77. http://dx.doi.org/10.1196/annals.1409.013.
Full text&NA;. "AN OUTBREAK OF PRIMARY PNEUMONIC TULAREMIA ON MARTHA???S VINEYARD." Infectious Diseases in Clinical Practice 11, no. 1 (January 2002): 39. http://dx.doi.org/10.1097/00019048-200201000-00019.
Full textReed, Douglas S., Emily Olsen, Jennifer Bowling, Katherine Willett, Karsten Hazlett, and Eileen Barry. "Role of antibody in vaccine-mediated protection against pneumonic tularemia in the rabbit model." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 168.12. http://dx.doi.org/10.4049/jimmunol.204.supp.168.12.
Full textBrunet, Camille D., Aurélie Hennebique, Julien Peyroux, Isabelle Pelloux, Yvan Caspar, and Max Maurin. "Presence of Francisella tularensis subsp. holarctica DNA in the Aquatic Environment in France." Microorganisms 9, no. 7 (June 28, 2021): 1398. http://dx.doi.org/10.3390/microorganisms9071398.
Full textMalik, Salma, Vishesh Paul, Thara Damodaran, Deepa Prabakhar, Amir Khan, and Sharjeel Ahmad. "648. Rapid, Non-invasive Detection of Cryptic Tularemia Using a Plasma-Based Microbial Cell-Free DNA Next-Generation Sequencing Test." Open Forum Infectious Diseases 8, Supplement_1 (November 1, 2021): S426. http://dx.doi.org/10.1093/ofid/ofab466.845.
Full textLembo, Annalisa, Mark Pelletier, Ravi Iyer, Michele Timko, Jan C. Dudda, T. Eoin West, Christopher B. Wilson, Adeline M. Hajjar, and Shawn J. Skerrett. "Administration of a Synthetic TLR4 Agonist Protects Mice from Pneumonic Tularemia." Journal of Immunology 180, no. 11 (May 19, 2008): 7574–81. http://dx.doi.org/10.4049/jimmunol.180.11.7574.
Full textChang, Yie-Hwa, Duc M. Duong, Johannes B. Goll, David C. Wood, Travis L. Jensen, Luming Yin, Casey E. Gelber, et al. "Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine." Vaccines 8, no. 3 (July 24, 2020): 413. http://dx.doi.org/10.3390/vaccines8030413.
Full textWu, Terry H., Julie A. Hutt, Kristin A. Garrison, Lyudmila S. Berliba, Yan Zhou, and C. Rick Lyons. "Intranasal Vaccination Induces Protective Immunity against Intranasal Infection with Virulent Francisella tularensis Biovar A." Infection and Immunity 73, no. 5 (May 2005): 2644–54. http://dx.doi.org/10.1128/iai.73.5.2644-2654.2005.
Full textMalik, Meenakshi, Chandra Shekhar Bakshi, Bikash Sahay, Aaloki Shah, Steven A. Lotz, and Timothy J. Sellati. "Toll-Like Receptor 2 Is Required for Control of Pulmonary Infection with Francisella tularensis." Infection and Immunity 74, no. 6 (June 2006): 3657–62. http://dx.doi.org/10.1128/iai.02030-05.
Full textHUSNA, ASHMA UL, MUNISH R ADHIKARI, DIVYA KHAREL, YAN JIANG, and GREGORY POLCHA. "UNDERSTANDING THE NEED FOR A BROAD DIFFERENTIAL DIAGNOSIS: A CASE OF PNEUMONIC TULAREMIA." Chest 162, no. 4 (October 2022): A560. http://dx.doi.org/10.1016/j.chest.2022.08.434.
Full textBossi, P., A. Tegnell, A. Baka, F. van Loock, A. Werner, J. Hendriks, H. Maidhof, and G. Gouvras. "Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia." Eurosurveillance 9, no. 12 (December 1, 2004): 27–28. http://dx.doi.org/10.2807/esm.09.12.00503-en.
Full textRay, Heather J., Yu Cong, Ashlesh K. Murthy, Dale M. Selby, Karl E. Klose, Jeffrey R. Barker, M. Neal Guentzel, and Bernard P. Arulanandam. "Oral Live Vaccine Strain-Induced Protective Immunity against Pulmonary Francisella tularensis Challenge Is Mediated by CD4+ T Cells and Antibodies, Including Immunoglobulin A." Clinical and Vaccine Immunology 16, no. 4 (February 11, 2009): 444–52. http://dx.doi.org/10.1128/cvi.00405-08.
Full textDembek, Z. F., R. L. Buckman, S. K. Fowler, and J. L. Hadler. "Missed Sentinel Case of Naturally Occurring Pneumonic Tularemia Outbreak: Lessons for Detection of Bioterrorism." Journal of the American Board of Family Medicine 16, no. 4 (July 1, 2003): 339–42. http://dx.doi.org/10.3122/jabfm.16.4.339.
Full textYaglom, Hayley, Edwin Rodriguez, Marlene Gaither, Mare Schumacher, Natalie Kwit, Christina Nelson, Joel Terriquez, et al. "Notes from the Field: Fatal Pneumonic Tularemia Associated with Dog Exposure — Arizona, June 2016." MMWR. Morbidity and Mortality Weekly Report 66, no. 33 (August 25, 2017): 891. http://dx.doi.org/10.15585/mmwr.mm6633a5.
Full textRusso, Brian C., Joseph Horzempa, Dawn M. O'Dee, Deanna M. Schmitt, Matthew J. Brown, Paul E. Carlson, Ramnik J. Xavier, and Gerard J. Nau. "A Francisella tularensis Locus Required for Spermine Responsiveness Is Necessary for Virulence." Infection and Immunity 79, no. 9 (June 13, 2011): 3665–76. http://dx.doi.org/10.1128/iai.00135-11.
Full textAnderson, Rebecca V., Deborah D. Crane, and Catharine M. Bosio. "Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs." Vaccine 28, no. 40 (September 2010): 6562–72. http://dx.doi.org/10.1016/j.vaccine.2010.07.072.
Full textSanapala, Shilpa, Jieh-Juen Yu, Ashlesh K. Murthy, Weidang Li, M. Neal Guentzel, James P. Chambers, Karl E. Klose, and Bernard P. Arulanandam. "Perforin- and Granzyme-Mediated Cytotoxic Effector Functions Are Essential for Protection against Francisella tularensis following Vaccination by the Defined F. tularensis subsp. novicida ΔfopCVaccine Strain." Infection and Immunity 80, no. 6 (April 9, 2012): 2177–85. http://dx.doi.org/10.1128/iai.00036-12.
Full textReed, Douglas S., Le'Kneitah Smith, Tammy Dunsmore, Anita Trichel, Luis A. Ortiz, Kelly Stefano Cole, and Eileen Barry. "Pneumonic Tularemia in Rabbits Resembles the Human Disease as Illustrated by Radiographic and Hematological Changes after Infection." PLoS ONE 6, no. 9 (September 13, 2011): e24654. http://dx.doi.org/10.1371/journal.pone.0024654.
Full textSchmitt, Deanna, Dawn O'Dee, Matthew Brown, Jospeh Horzempa, Brian Russo, and Gerard Nau. "IL-15/IL-15Rα improves immune cell survival but does not reduce disease severity following pulmonary infection with the intracellular bacterium Francisella tularensis (56.27)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 56.27. http://dx.doi.org/10.4049/jimmunol.186.supp.56.27.
Full textLi, Zilu, Daniel L. Clemens, Bai-Yu Lee, Barbara Jane Dillon, Marcus A. Horwitz, and Jeffrey I. Zink. "Mesoporous Silica Nanoparticles with pH-Sensitive Nanovalves for Delivery of Moxifloxacin Provide Improved Treatment of Lethal Pneumonic Tularemia." ACS Nano 9, no. 11 (October 9, 2015): 10778–89. http://dx.doi.org/10.1021/acsnano.5b04306.
Full textBar-On, Liat, Hila Cohen, Uri Elia, Shahar Rotem, Adi Bercovich-Kinori, Erez Bar-Haim, Theodor Chitlaru, and Ofer Cohen. "Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung." Vaccine 35, no. 50 (December 2017): 7001–9. http://dx.doi.org/10.1016/j.vaccine.2017.10.053.
Full textStinson, Elizabeth, Le'Kneitah P. Smith, Kelly Stefano Cole, Eileen M. Barry, and Douglas S. Reed. "Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model." Pathogens and Disease 74, no. 7 (August 9, 2016): ftw079. http://dx.doi.org/10.1093/femspd/ftw079.
Full textPriyantha, M. A. R. "Francisella tularensis: a zoonotic pathogen among wild rodents and arthropods - a possible threat in future." Sri Lanka Veterinary Journal 70, no. 1 (September 6, 2023): 13–21. http://dx.doi.org/10.4038/slvj.v70i1.76.
Full textSutherland, Marjorie D., Andrew W. Goodyear, Ryan M. Troyer, Jeffrey C. Chandler, Steven W. Dow, and John T. Belisle. "Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia." Vaccine 30, no. 33 (July 2012): 4977–82. http://dx.doi.org/10.1016/j.vaccine.2012.05.037.
Full textKouadio, Koffi Isidore, Taro Kamigaki, and Hitoshi Oshitani. "Strategies for Communicable Diseases Response After Disasters in Developing Countries." Journal of Disaster Research 4, no. 5 (October 1, 2009): 298–308. http://dx.doi.org/10.20965/jdr.2009.p0298.
Full textClemens, Daniel L., Bai-Yu Lee, Sheba Plamthottam, Michael V. Tullius, Ruining Wang, Chia-Jung Yu, Zilu Li, Barbara Jane Dillon, Jeffrey I. Zink, and Marcus A. Horwitz. "Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model." ACS Infectious Diseases 5, no. 2 (November 27, 2018): 281–91. http://dx.doi.org/10.1021/acsinfecdis.8b00268.
Full textLee, Bai-Yu, Zilu Li, Daniel L. Clemens, Barbara Jane Dillon, Angela A. Hwang, Jeffrey I. Zink, and Marcus A. Horwitz. "Redox-Triggered Release of Moxifloxacin from Mesoporous Silica Nanoparticles Functionalized with Disulfide Snap-Tops Enhances Efficacy Against Pneumonic Tularemia in Mice." Small 12, no. 27 (June 1, 2016): 3690–702. http://dx.doi.org/10.1002/smll.201600892.
Full textFuruya, Yoichi, Girish S. Kirimanjeswara, Sean Roberts, and Dennis W. Metzger. "Increased Susceptibility of IgA-Deficient Mice to Pulmonary Francisella tularensis Live Vaccine Strain Infection." Infection and Immunity 81, no. 9 (July 8, 2013): 3434–41. http://dx.doi.org/10.1128/iai.00408-13.
Full textRodriguez, Annette Rose, JiehJuen Yu, Ashlesh Murthy, M. Neal Guentzel, Karl E. Klose, James P. Chambers, Thomas G. Forsthurber, Michael T. Berton, and Bernard P. Arulanandam. "Mast cells induce alternative activation and inhibit caspase-3 mediated apoptosis of Francisella tularensis infected macrophages (44.24)." Journal of Immunology 182, no. 1_Supplement (April 1, 2009): 44.24. http://dx.doi.org/10.4049/jimmunol.182.supp.44.24.
Full textWest, T. Eoin, Mark R. Pelletier, Melanie C. Majure, Annalisa Lembo, Adeline M. Hajjar, and Shawn J. Skerrett. "Inhalation of Francisella novicida ΔmglA causes replicative infection that elicits innate and adaptive responses but is not protective against invasive pneumonic tularemia." Microbes and Infection 10, no. 7 (June 2008): 773–80. http://dx.doi.org/10.1016/j.micinf.2008.04.008.
Full textBalagopal, Ashwin, Amanda Shearer MacFarlane, Nrusingh Mohapatra, Shilpa Soni, John S. Gunn, and Larry S. Schlesinger. "Characterization of the Receptor-Ligand Pathways Important for Entry and Survival of Francisella tularensis in Human Macrophages." Infection and Immunity 74, no. 9 (September 2006): 5114–25. http://dx.doi.org/10.1128/iai.00795-06.
Full textHorzempa, Joseph, Dawn M. O'Dee, Robert M. Q. Shanks, and Gerard J. Nau. "Francisella tularensis ΔpyrF Mutants Show that Replication in Nonmacrophages Is Sufficient for Pathogenesis In Vivo." Infection and Immunity 78, no. 6 (April 12, 2010): 2607–19. http://dx.doi.org/10.1128/iai.00134-10.
Full textBarrigan, Lydia, Shraddha Tuladhar, Jason Brunton, Matthew Woolard, Ching-ju Chen, Divey Saini, Richard Frothingham, Gregory Sempowski, Thomas Kawula, and Jeffrey Frelinger. "Altered host immune responses, not lowered growth, are the mechanism of attenuation of Francisella tularensis clpB (P3126)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 186.10. http://dx.doi.org/10.4049/jimmunol.190.supp.186.10.
Full textWyatt, Elliott V., Karina Diaz, Amanda Griffin, Jed Rasmussen, Deborah Crane, Bradley Jones, and Catharine M. Bosio. "Optimal replication and suppression of inflammation by virulent Francisella tularensis is achieved through reprogramming of host glycolysis." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 66.7. http://dx.doi.org/10.4049/jimmunol.196.supp.66.7.
Full text